How big is the Australia Pharmaceuticals Market?

The Australia Pharmaceuticals Market size is expected to reach USD 13.21 billion in 2024 and grow at a CAGR of 6.25% to reach USD 17.89 billion by 2029. Read More

What is the current Australia Pharmaceuticals Market size?

In 2024, the Australia Pharmaceuticals Market size is expected to reach USD 13.21 billion. Read More

What years does this Australia Pharmaceuticals Market cover, and what was the market size in 2023?

In 2023, the Australia Pharmaceuticals Market size was estimated at USD 12.38 billion. The report covers the Australia Pharmaceuticals Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Pharmaceuticals Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the challenges for foreign pharma companies entering the Australian Market?

The challenges for foreign pharma companies entering the Australian Market are a) Competition b) Regulatory hurdles c) Potential need for local partnerships Read More

What are the challenges for foreign pharma companies entering the Australian Market?

The challenges for foreign pharma companies entering the Australian Market are a) Competition b) Regulatory hurdles c) Potential need for local partnerships Read More

Australia Pharmaceuticals Companies

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Top Companies in Australia Pharmaceuticals Market

This report lists the top Australia Pharmaceuticals companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Australia Pharmaceuticals industry.

Abbvie
Amgen
AstraZeneca
Eli Lilly and Company
Pfizer

*Disclaimer: Top companies sorted in no particular order

Australia Pharmaceuticals Market Major Players

Australia Pharmaceuticals Market Concentration

Australia Pharmaceuticals Company List

1. INTRODUCTION
1. 1.1 Study Assumptions and Market Definition
2. 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Rising Geriatric Population and Increasing Investments in the Sector
  2. 4.2.2 Rising Incidence of Chronic Diseases such as CVD and Diabetes
3. 4.3 Market Restraints
  1. 4.3.1 Stringent Regulatory Scenario
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products and/ or Services
  5. 4.4.5 Degree of Competition/Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Million)
1. 5.1 By ATC/Therapeutic Class
  1. 5.1.1 Alimentary Tract and Metabolism
  2. 5.1.2 Blood and Blood Forming Organs
  3. 5.1.3 Cardiovascular System
  4. 5.1.4 Dermatologicals
  5. 5.1.5 Genito Urinary System and Sex Hormones
  6. 5.1.6 Systemic Hormonal Preparations
  7. 5.1.7 Anti-infectives for Systemic Use
  8. 5.1.8 Antineoplastic and Immunomodulating Agents
  9. 5.1.9 Musculoskeletal System
  10. 5.1.10 Nervous System
  11. 5.1.11 Antiparasitic Products, Insecticides, and Repellents
  12. 5.1.12 Respiratory System
  13. 5.1.13 Sensory Organs
  14. 5.1.14 Other Therapeutic Classes
2. 5.2 By Drug Type
  1. 5.2.1 Branded
  2. 5.2.2 Generic
3. 5.3 By Prescription Type
  1. 5.3.1 Prescription Drugs (Rx)
  2. 5.3.2 OTC Drugs
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 AbbVie Inc.
  2. 6.1.2 AstraZeneca PLC
  3. 6.1.3 Amgen Inc.
  4. 6.1.4 Pfizer Inc.
  5. 6.1.5 CSL Limited
  6. 6.1.6 F. Hoffmann-La Roche AG
  7. 6.1.7 GlaxoSmithKline PLC
  8. 6.1.8 Eli Lilly and Company
  9. 6.1.9 Novartis AG
  10. 6.1.10 Sanofi SA
  11. 6.1.11 Johnson and Johnson
  12. 6.1.12 Merck KGaA
2. *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Specific to Australia Pharmaceuticals Market

Need More Details On Market Players And Competitors?

Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Australia Pharmaceuticals Market Companies Summary

The pharmaceutical market in Australia saw a significant impact from the COVID-19 pandemic, with numerous firms gaining approval for their vaccines against the virus and focusing their research and development on COVID-19 therapeutics. The Australian government supported these efforts by investing heavily in vaccine supply and research and development activities related to COVID-19 prevention and treatment. This led to an acceleration of market growth during the pandemic. Moreover, the government assembled a large group of clinical experts to form a taskforce, creating evidence-based guidelines for the clinical care of COVID-19 patients. The market growth is also driven by the increasing burden of chronic diseases and the rising geriatric population, along with increasing investments in research and development for novel therapeutics. Major market players have adopted key strategies, increased investment, and intensified research and development activities, contributing to market growth. However, strict regulatory guidelines for product approvals are expected to hinder market growth. The Australian pharmaceutical market is highly competitive, with several major players dominating the market. These prominent players are actively making acquisitions and joint ventures with other companies to consolidate their market positions.

Explore More